Michael Horowicz

Broermann Holding GmbH engages in the acquisition, management, and financing of firms, particularly hospitals and healthcare, hotels, and real estate sectors. The firm provides consulting services to such firms. The company was founded on June 19, 1985 and is headquartered in Koenigstein im Taunus, Germany.

Vanguard AG engages in the development, manufacture, and sale of medical devices and equipment used for cardiology and endoscopy. The company was founded by Bernard Frieling and Robert Schrödel in 1998 and is headquartered in Berlin, Germany.

Asklepios Kliniken Hamburg GmbH owns and operates hospitals in Hamburg. It is engaged in general and acute medical care and therapeutic services. The firm's services include hospitalization, emergency care service, surgery and ambulatory care services. The company was founded in 1995 and is headquartered in Hamburg, Germany

Part of Ernst & Young Global Ltd., Arthur Andersen & Co. GmbH is a German company.

AFFiRiS AG develops and produces vaccines for therapeutic treatment of chronic diseases. It provides research services and develops vaccines based on peptide antigens applied in the fields of biochemistry, molecular and cell biology, immunology and veterinary medicine. AFFiRiS was founded by Walter Schmidt and Frank Mattner in November 2003 and is headquartered in Vienna, Austria.

APK AG provides recovery services of raw materials such as fossil fuels like oil, coal, gas, and renewable resources like plants. It also provides grinding and screening processes for hard rocks. The company was founded by Wolfgang Lindner in 2008 and is headquartered in Merseburg, Germany.

Trilantic Capital Partners LLP operates as an alternative investment manager. The company was founded by Vittorio Pignatti-Morano, Javier Banon, and Joe Cohen in April 2009 and is headquartered in London, the United Kingdom.

JPT Peptide Technologies GmbH provides innovative peptide based products and services for vaccine development, immune monitoring and peptide biomarker discovery. The firm’s products include custom peptides, modified & labeled peptides, clinical peptides, stable isotope-labeled peptides, SPOT peptides, immunogenic peptides, peptide libraries, peptide pools, peptide microarrays, peptide ELISA, enzyme profiling and epitope discovery service. The company was founded in 2004 and is headquartered in Berlin, Germany.

AiCuris GmbH & Co. KG provides research and development services for antiviral and antibacterial agents. The firm develops drugs against viruses such as human cytomegalovirus, herpes simplex virus, hepatitis B virus and human immunodeficiency virus. The company was founded in March 2006 and is headquartered in Wuppertal, Germany.

Universitätsmedizin der Johannes Gutenberg-Universität Mainz KöR owns and operates medical institutions and clinics. It offers nursing and optimal patient care, diagnostic, care management, and other related healthcare services. The company is headquartered in Mainz, Germany.

Founded in 1962, Kraichgau-Klinik AG is a subsidiary of Asklepios Kliniken GmbH & Co. KGaA and operates hospitals. The company is based in Bad Rappenau, Germany.

Part of MediClin AG, MediClin Geschäftsführungs GmbH is a company based in Offenburg, Germany. The CEOs of the German company are Volker Hippler, Phillip Fröschle, Ute Haase, Philipp Schlösser, Tino Marco Fritz. MediClin Geschäftsführungs GmbH provides investment services.

Part of MediClin AG, MediClin Medizinisches Versorgungszentrum GmbH provides administration and management services. The company is based in Offenburg, Germany. The German company was founded in 1998. Ute Haase has been the CEO of the company since 2020.

CorTec GmbH develops a neuro-technological platform for brain activity measurement and stimulation. The firm specializes in the designing a platform based on the CorTec Brain Interchange technology, with focus on opening up therapeutic and diagnostic possibilities. Its application areas encompass treatment, rehabilitation, and assistance technique. The firm also engages in research and development partnerships that deal with technology development programs and funding initiatives. The company was founded by Thomas Stieglitz, Wolfgang Meier, Christina Schwartz, Jorn Rickert, Markus Raab, Christian Henle, Martin Schuttler, and Jorg Fischer in September 2010 and is headquartered in Freiburg, Germany.

Part of Jossa Arznei GmbH, Pharma Radebeul GmbH is a company that specializes in rentals and leases of industrial machinery. The company is based in Radebeul, Germany. Michael Riemenschneider has been the CEO of the German company since 2020.

BioNTech Small Molecules GmbH engages in the research and development of synthetic compounds against cancer and other diseases. The company was founded on April 11, 2016 and is headquartered in Mainz, Germany.

Dr. Ernst Strüngmann Foundation gGmbH is a biotechnology research and development company based in Munich, Germany. Dr. Ernst Strüngmann Foundation gGmbH engages in research and development on biotechnology. The German company was founded in 2007, and its CEOs are Andreas Strüngmann, Thomas Strüngmann, and Thomas Maier.

ATB GmbH is an investment holding German company founded in 2004. The private company is based in Gera, Germany.

Asklepios Kliniken GmbH & Co. KGaA engages in the management and operation of hospitals and health centers. It offers medical services in the fields of anesthesiology, geriatrics, cardiology, surgery, internal medicine, neurology, psychiatry, orthopedics, radiology, nuclear medicine, and urology. The company was founded by Bernard grosse Broermann in 1985 and is headquartered in Hamburg, Germany.

Marienhaus gGmbH is a non-profit company based in Essen, Germany. However, there is an update available on the German company's website, and additional information can be downloaded from there. The company was founded in 1864 and the CEO is Hubertus Volmer.

Part of Santo Holding (Deutschland) GmbH, Aicuris Anti-Infective Cures AG aims to discover, develop, and deliver innovative, anti-viral drugs to immunocompromised patients aiming to prevent severe condition and life-threatening diseases. The company is based in Wuppertal, Germany. Aicuris has developed a commercial drug as well as pipeline of clinical-stage and pre-clinical anti-viral candidates. Its lead product Prevymis® (letermovir), a first-in-class non-nucleoside cytomegalovirus (CMV) inhibitor, was licensed to MSD and is commercialized for the prevention of human CMV infections in immunocompromised patients who underwent an allogeneic hematopoietic stem cell transplantation or kidney transplantation. Aicuris wholly owned product candidate, Pritelivir, targeting resistant herpes simplex virus (HSV) infections in immunocompromised patients, is in phase 3 clinical development. The German company was founded in 2006 by Helga Rübsamen-Schaeff. Larry G. Edwards has been the CEO of the company since 2023.

IQM Finland Oy operates as a quantum computing company. It engages in building hardware for quantum computers that focuses on superconducting technology. The company was founded by Juha Johannes Vartiainen, Kuan Yen Tan, Jan Goetz, and Mikko Pentti Matias M?tt?nen and is headquartered in Espoo, Finland.

Part of BioNTech SE, BioNTech Delivery Technologies GmbH is a German company that engages in research and development of immunotherapies. The company is based in Halle, Germany. The CEOs of the company are Ugur Sahin, Sierk Poetting.

Asklepios Westklinikum Hamburg GmbH provides health care services. Their specialist departments ensure primary and secondary care in the Hamburg West surgery and orthopaedics, neurosurgery, urology, internal medicine, geriatrics, ENT, psychiatry and Psychosomatic Medicine with their a wide range of services. In addition to the General supply all their departments have also dedicated specializations. The company is headquartered in Hamburg, Germany.

Part of Fresenius SE & Co. KGaA, Fresenius Kabi Deutschland GmbH is a healthcare company based in Bad Homburg vor der Hohe, Germany. The CEOs are Steffen Roser, Christoph Funke, Tanja Greve. Fresenius Kabi creates an environment of mutual respect, encouragement, and teamwork. The German company specializes in lifesaving medicines and technologies for infusion, transfusion, and clinical nutrition. The company is also specialized in the field of oncology products supported by integrated manufacturing, regulatory, sales, marketing & distribution set up. The company has summarized their expectations towards their suppliers and business partners in a suppliers code of conduct and a business partner code of conduct. The company was founded in 1999.